Crestpoint Psychiatric Care

Crestpoint Psychiatric Care in Johnson City, Tennessee offers Spravato for adults with treatment-resistant depression and major depressive disorder with acute suicidal ideation. The intranasal esketamine is used in conjunction with an oral antidepressant and administered on site, with patients required to have a designated driver since they cannot drive for 24 hours after treatment.

Led by Dr. Aimua, who is board-certified in psychiatry by the American Board of Psychiatry and Neurology with over fifteen years of experience, the practice combines medication management with psychotherapeutic interventions. Spravato is the first and only NMDA receptor antagonist approved for two subtypes of MDD.

The clinic also offers TMS, a medication-free, non-invasive treatment FDA-approved for major depressive disorder, anxiety, and OCD, as well as GeneSight pharmacogenomic testing. Crestpoint provides individualized psychiatric care for a broad range of conditions.